Establishment Labs Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.08.23	Establishment Labs Reports Record Second Quarter 2023 Financial Results (Businesswire)
07.08.23	Ausblick: Establishment Labs informiert über die jüngsten Quartalsergebnisse (finanzen.net)
26.07.23	Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8 (Businesswire)
19.07.23	Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities (Businesswire)
31.05.23	Establishment Labs to Participate in Two Upcoming Investor Conferences (Businesswire)
30.05.23	Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools (Businesswire)
08.05.23	Establishment Labs Reports Record First Quarter 2023 Financial Results (Businesswire)
07.05.23	Ausblick: Establishment Labs legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
27.04.23	Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares (Businesswire)
26.04.23	Establishment Labs to Announce First Quarter 2023 Financial Results on May 8 (Businesswire)
25.04.23	Establishment Labs Announces Pricing of Public Offering of Common Shares (Businesswire)
24.04.23	Establishment Labs Announces Proposed Public Offering of Common Shares (Businesswire)
24.04.23	Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023 (Businesswire)
20.04.23	Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023 (Businesswire)
10.04.23	Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan (Businesswire)
03.04.23	Establishment Labs Announces Participation in The Aesthetic Meeting 2023 (Businesswire)
29.03.23	Establishment Labs Surpasses Three Million Motiva Devices (Businesswire)
23.03.23	Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan (Businesswire)
01.03.23	ROSEN, A LEADING LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
28.02.23	Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference (Businesswire)
27.02.23	Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results (Businesswire)
18.02.23	ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
13.02.23	Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27 (Businesswire)
09.01.23	Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022 (Businesswire)
03.01.23	Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™ (Businesswire)
28.12.22	Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
10.11.22	Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction (Businesswire)
07.11.22	Establishment Labs Reports Third Quarter 2022 Financial Results (Businesswire)
06.11.22	Ausblick: Establishment Labs verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
01.11.22	Establishment Labs Announces Participation in Two Upcoming Investment Conferences (Businesswire)
24.10.22	Establishment Labs to Announce Third Quarter 2022 Financial Results on November 7 (Businesswire)
21.10.22	ESTA INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
20.09.22	Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022 (Businesswire)
12.09.22	Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch (Businesswire)
08.08.22	Establishment Labs Reports Record Second Quarter 2022 Financial Results (Businesswire)
07.08.22	Ausblick: Establishment Labs stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
03.08.22	Establishment Labs Announces Complete Enrollment in Motiva US IDE Study (Businesswire)
25.07.22	Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8 (Businesswire)
19.07.22	Establishment Labs Releases 2021 Sustainability Review (Businesswire)
06.06.22	Establishment Labs to Present at the Jefferies Healthcare Conference (Businesswire)
10.05.22	ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2 (RTTNews)
09.05.22	Establishment Labs Reports Record First Quarter 2022 Financial Results (Businesswire)
08.05.22	Ausblick: Establishment Labs gewährt Anlegern Blick in die Bücher (finanzen.net)
28.04.22	Establishment Labs to Announce First Quarter 2022 Financial Results on May 9 (Businesswire)
26.04.22	Establishment Labs Enters Into $225 Million Credit Facility With Oaktree (Businesswire)
22.04.22	Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022 (Businesswire)
11.04.22	Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest (Businesswire)
02.03.22	Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference (Businesswire)
01.03.22	Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million (Businesswire)
28.02.22	Ausblick: Establishment Labs präsentiert Quartalsergebnisse (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Establishment Labs Holdings Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten